Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Supportive Cancer Therapy|July 18, 2008
Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trialThorvardur R Halfdanarson, Aminah Jatoi
Current Oncology Reports|May 4, 2010
Oral cancer chemotherapy: the critical interplay between patient education and patient safetyThorvardur R Halfdanarson, Aminah Jatoi
Current Treatment Options in Oncology|August 21, 2019
Management of Well-Differentiated High-Grade (G3) Neuroendocrine TumorsMohamad Bassam Sonbol, Thorvardur R Halfdanarson
Current Clinical Pharmacology|November 10, 2015
Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine MalignanciesThorvardur R Halfdanarson, Jonathan R Strosberg
Cancers|September 27, 2025
Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRTAman Chauhan, Thorvardur R Halfdanarson, Namrata Vijayvergia
Rare Tumors|December 21, 2016
Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012Leslie Padrnos, Nina Karlin, Thorvardur R Halfdanarson
JAMA Oncology|April 17, 2020
Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic ReviewMohamad Bassam Sonbol, Thorvardur R Halfdanarson, Talal Hilal
Seminars in Oncology|December 13, 2018
Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumorsJohn Ramage, Boris G Naraev, Thorvardur R Halfdanarson
Cancer Journal (Sudbury, Mass.)|April 21, 2010
The role of chemotherapy in managing patients with resectable liver metastasesThorvardur R Halfdanarson, Michael L Kendrick, Axel Grothey
F1000Research|December 12, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Supportive Cancer Therapy|July 18, 2008
Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trialThorvardur R Halfdanarson, Aminah Jatoi
Current Oncology Reports|May 4, 2010
Oral cancer chemotherapy: the critical interplay between patient education and patient safetyThorvardur R Halfdanarson, Aminah Jatoi
Current Treatment Options in Oncology|August 21, 2019
Management of Well-Differentiated High-Grade (G3) Neuroendocrine TumorsMohamad Bassam Sonbol, Thorvardur R Halfdanarson
Current Clinical Pharmacology|November 10, 2015
Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine MalignanciesThorvardur R Halfdanarson, Jonathan R Strosberg
Cancers|September 27, 2025
Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRTAman Chauhan, Thorvardur R Halfdanarson, Namrata Vijayvergia
Rare Tumors|December 21, 2016
Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012Leslie Padrnos, Nina Karlin, Thorvardur R Halfdanarson
JAMA Oncology|April 17, 2020
Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic ReviewMohamad Bassam Sonbol, Thorvardur R Halfdanarson, Talal Hilal
Seminars in Oncology|December 13, 2018
Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumorsJohn Ramage, Boris G Naraev, Thorvardur R Halfdanarson
Cancer Journal (Sudbury, Mass.)|April 21, 2010
The role of chemotherapy in managing patients with resectable liver metastasesThorvardur R Halfdanarson, Michael L Kendrick, Axel Grothey
F1000Research|December 12, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
Pageof 22